Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
613P - Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer
If you overindulged during the holidays and are choosing baggier clothes to hide the rolls around your middle, youre certainly not alone
It depicts three sensor types: the untreated (GO-0s) with more oxygen leading to stronger chemisorption, the optimally treated (rGO 10 s) showing a balanced interaction, and the extensively treated (rGO 240 s) with fewer oxygen groups resulting in reduced sensitivity
154 RizzoM.AbateN.ChandaliaM.RizviA
Coverage varies significantly
US$ 23.32
US$ 27.01
US$ 20.74
US$ 20.66
US$ 21.76
US$ 26.33
US$ 20.72
US$ 23.22
